/Unitedhealth%20Group%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
UnitedHealth Group (UNH) has recently emerged as one of Wall Street’s most discussed – and most criticized – stocks. After years of steady growth, the company’s stock has fallen roughly 40% year-to-date in 2025, making it one of the worst-performing S&P 500 Index ($SPX) stocks this year. The stock has also dropped nearly 52% from its 52-week high of $630.73.
While the market is bearish on UNH stock, I believe the majority of its problems are only temporary and that it will recover. This could be a rare opportunity to buy this blue-chip stock at a discount.